TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Soligenix, Inc. (NASDAQ: SNGX) Investor Investigation Over Possible Wrongdoing Announced

  • Investors who purchased shares of Soligenix, Inc. (NASDAQ: SNGX) have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Soligenix, Inc.
Security
NASDAQ: SNGX

Summary

An investigation on behalf of investors in shares of Soligenix, Inc. (NASDAQ: SNGX) was announced over potential breaches of fiduciary duties by certain officers and directors at Soligenix, Inc.

The investigation by a law firm concerns whether certain Soligenix, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.

Princeton, NJ based Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. Soligenix, Inc. reported that its annual Total Revenue declined from over $10.44 million in 2016 to over $5.43 million in 2017 and that its Net Loss increased from over $3.24 million in 2016 to over $7.14 million in 2017.

Shares of Soligenix, Inc. (NASDAQ: SNGX) declined to as low as $0.91 per share in June 2018.

Start Monitoring Your Investments